开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-08-07 于陌上来自吉林省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学
经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept

42 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-11-09 默默0606 来自北京

偏重的研究方向：细胞生物学
经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……

107 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-12-28 ms5000000204318340 来自山东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2023.9.26 Submitted to journal
2023.9.30 With Editor
2023.10.3 Under review
2023.11.3 Required reviews completed
2023.11.13 Major revision
2023.12.25 Revision submitted to journal
2023.12.26 With Editor
2023.12.26 Under review
2023.12.27 Required reviews completed
2023.12.27 Accept

101 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-10-16 科研小麻瓜来自广东省

这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？

117 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2021-11-16 山蛙

审稿速度:2.0 | 投稿命中率:25.0
经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。

157 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-08-09 ms2000000705029865

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：分子生物学;肿瘤;分子机制
经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好

115 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-02-26 ms4000000389646164 来自浙江省

no

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-02-26 ms4000000389646164 来自浙江省

no

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-02-20 ms2000000711984129 来自广东省

请问大家，这个杂志有几个reviewer

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2218885, encodeId=18f3221888523, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学 经验分享：2023.9.1 submitted to journal 2023.9.1 with editor 2023.9.19 with editor 2023.10.26 Under Review 2023.11.17 Under Review 2023.11.30 Under Review 2023.12.17 Under Review 2024.1.7 Under Review 2024.1.9 Under Review 2024.2.6 Under Review 2024.3.3 Under Review 2024.3.22 Required Reviews completed 2024.3.24 Major Revision (Date Revision Due 2024.5.5) 2024.5.5 Revision Submitted to Journal 2024.5.6 with editor 2024.5.20 Under Review 2024.6.6 major Revision (Date Revision Due 2024.7.17) 2024.7.17 Revision Submitted to Journal 2024.7.18 with editor 2024.7.22 Under Review 2024.8.6 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Wed Aug 07 05:56:17 CST 2024, time=2024-08-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向：细胞生物学 经验分享：这个杂志一开始看评论很快，大概七月底投得，with editor三周，可是under review将近三个月了还是under review，这是怎么了，急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.9.26 Submitted to journal 2023.9.30 With Editor 2023.10.3 Under review 2023.11.3 Required reviews completed 2023.11.13 Major revision 2023.12.25 Revision submitted to journal 2023.12.26 With Editor 2023.12.26 Under review 2023.12.27 Required reviews completed 2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事，投稿近一个月还是with editor，转OA了变慢了吗？我想三月份见刊，还有没有戏，等多久催编辑部呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：欧洲老牌杂志，三天内with editor, 十天内Under review，一个月内Minor revision,要求文章创新性比较高，数据全面且研究深入，审稿人意见比较专业，提了许多比较细的问题，总的来说还是比较难投，感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家，这个杂志有几个reviewer , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-11-18 33333333

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：等了一个月，编辑说没找到审稿人........这杂志是不是不太行

0 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务